Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A systematic review and meta-analysis of observational studies and uncontrolled trials reporting on the use of checkpoint blockers in patients with cancer and pre-existing autoimmune disease.
Lopez-Olivo MA, Kachira JJ, Abdel-Wahab N, Pundole X, Aldrich JD, Carey P, Khan M, Geng Y, Pratt G, Suarez-Almazor ME. Lopez-Olivo MA, et al. Eur J Cancer. 2024 Aug;207:114148. doi: 10.1016/j.ejca.2024.114148. Epub 2024 May 31. Eur J Cancer. 2024. PMID: 38834015 Review.
Patient Voices in Rheumatic Immune-related Adverse Events.
Corps KN, Terry O, Lopez-Olivo MA. Corps KN, et al. Among authors: lopez olivo ma. Rheum Dis Clin North Am. 2024 May;50(2):241-254. doi: 10.1016/j.rdc.2024.01.006. Epub 2024 Feb 22. Rheum Dis Clin North Am. 2024. PMID: 38670723 Review.
Generating a list of potentially important contextual factors covering randomized trials, cohorts, and measurement property studies: An OMERACT initiative.
Weinbrecht-Mischkewitz M, Kamal M, Asim F, Guillemin F, Goel N, Voshaar M, Boonen A, Berthelsen DB, Toupin-April K, Lopez-Olivo MA, Sloan VS, Boers M, Jones CA, van der Horst-Bruinsma I, Cashin AG, Sharma S, Leong A, Alten R, Shea B, March L, Tugwell P, Christensen R, Nielsen SM; Contextual Factors Working Group. Weinbrecht-Mischkewitz M, et al. Among authors: lopez olivo ma. Semin Arthritis Rheum. 2024 Apr;65:152370. doi: 10.1016/j.semarthrit.2024.152370. Epub 2024 Jan 10. Semin Arthritis Rheum. 2024. PMID: 38290371 Free article.
Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases.
Reid P, Sandigursky S, Song J, Lopez-Olivo MA, Safa H, Cytryn S, Efuni E, Buni M, Pavlick A, Krogsgaard M, Abu-Shawer O, Altan M, Weber JS, Rahma OE, Suarez-Almazor ME, Diab A, Abdel-Wahab N. Reid P, et al. Among authors: lopez olivo ma. Oncoimmunology. 2023 Oct 30;12(1):2261264. doi: 10.1080/2162402X.2023.2261264. eCollection 2023. Oncoimmunology. 2023. PMID: 38126033 Free PMC article.
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set.
Benavent D, Carmona L, Lopez-Olivo MA, Hill CL, Westrich-Robertson T, Goel N, Strand V, Shea B, Grosskleg S, Leong A, Hofstetter C, Bingham C, Meyer D, Constien D, Berthelsen DB, Schultz G, de Groot I, Weiner J, Mather K, de Wit M, Böhm P, Cembalo SM, Tugwell P, Bruera S, Suarez-Almazor ME. Benavent D, et al. Among authors: lopez olivo ma. Semin Arthritis Rheum. 2024 Feb;64:152343. doi: 10.1016/j.semarthrit.2023.152343. Epub 2023 Dec 13. Semin Arthritis Rheum. 2024. PMID: 38118370
119 results